loadpatents
Patent applications and USPTO patent grants for Mizui; Yoshiharu.The latest application filed is for "splice variants associated with neomorphic sf3b1 mutants".
Patent | Date |
---|---|
Splice Variants Associated With Neomorphic Sf3b1 Mutants App 20210130909 - Yu; Lihua ;   et al. | 2021-05-06 |
Splice variants associated with neomorphic SF3B1 mutants Grant 10,889,866 - Yu , et al. January 12, 2 | 2021-01-12 |
Splice Variants Associated With Neomorphic Sf3b1 Mutants App 20180318312 - Yu; Lihua ;   et al. | 2018-11-08 |
Macrocyclic Compounds Useful As Pharmaceuticals App 20130196987 - Boivin; Roch ;   et al. | 2013-08-01 |
Macrocyclic compounds useful as pharmaceuticals Grant 8,329,742 - Boivin , et al. December 11, 2 | 2012-12-11 |
Macrocyclic Compounds Useful As Pharmaceuticals App 20110144101 - Boivin; Roch ;   et al. | 2011-06-16 |
Macrocyclic compounds useful as pharmaceuticals Grant 7,915,306 - Chiba , et al. March 29, 2 | 2011-03-29 |
Macrocyclic compounds useful as pharmaceuticals Grant 7,799,827 - Boivin , et al. September 21, 2 | 2010-09-21 |
Method For Assaying Action Of Antitumor Agent Using Decrease In Gene Expression Level As Index App 20100086931 - Mizui; Yoshiharu ;   et al. | 2010-04-08 |
Bioactive substance Grant 7,667,052 - Mizui , et al. February 23, 2 | 2010-02-23 |
Method For Assaying Action Of Antitumor Agent Using Splicing Defects As Index App 20100021918 - Mizui; Yoshiharu ;   et al. | 2010-01-28 |
Target Molecules Of Pladienolides, Compounds Binding To Such Target Molecules, And Screening Method Thereof App 20090227795 - Kotake; Yoshihiko ;   et al. | 2009-09-10 |
Macrocyclic compounds useful as pharmaceuticals App 20060247448 - Boivin; Roch ;   et al. | 2006-11-02 |
Novel bioactive substance App 20060079572 - Mizui; Yoshiharu ;   et al. | 2006-04-13 |
Physiologically active substances Grant 7,026,352 - Mizui , et al. April 11, 2 | 2006-04-11 |
Macrocyclic compounds useful as pharmaceuticals App 20040224936 - Chiba, Kenichi ;   et al. | 2004-11-11 |
Human antithrombin III mutants Grant 5,420,252 - Kato , et al. May 30, 1 | 1995-05-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.